Literature DB >> 11228367

Immune reactions of CD4- and CD8-positive T cell subpopulations in spleen and lymph nodes of guinea pigs after vaccination with Bacillus Calmette Guerin.

T Klünner1, T Bartels, M Vordermeier, R Burger, H Schäfer.   

Abstract

Vaccination of guinea pigs with Mycobacterium bovis BCG confers partial resistance against infection with Mycobacterium tuberculosis. Induction of immunity is associated with a strong T cell response. The reactions of the cytotoxic and helper T lymphocyte subsets after BCG vaccination were analyzed by cytofluorometry and in functional tests. The relative number of CD8(+) T cells in the spleen increased substantially after injection of BCG. In vitro restimulation after immunization induced a strong proliferative response but no cytotoxic reactions of CD8(+) T cells against BCG-infected macrophages. A specific induction of IFN-gamma and RANTES mRNA was observed after vaccination particularly in CD8(+) but not in CD4(+) T cells of the lymph nodes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11228367     DOI: 10.1016/s0264-410x(00)00429-1

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  7 in total

1.  Dynamics of gamma interferon, interleukin-12 (IL-12), IL-10, and transforming growth factor beta mRNA expression in primary Mycobacterium bovis BCG infection in guinea pigs measured by a real-time fluorogenic reverse transcription-PCR assay.

Authors:  Mamoru Kawahara; Tadashi Nakasone; Mitsuo Honda
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

2.  Development of a guinea pig immune response-related microarray and its use to define the host response following Mycobacterium bovis BCG vaccination.

Authors:  Julia A Tree; Michael J Elmore; Sajid Javed; Ann Williams; Philip D Marsh
Journal:  Infect Immun       Date:  2006-02       Impact factor: 3.441

3.  Effect of Mycobacterium bovis BCG vaccination on interleukin-1 beta and RANTES mRNA expression in guinea pig cells exposed to attenuated and virulent mycobacteria.

Authors:  Amminikutty Jeevan; Teizo Yoshimura; Gregory Foster; David N McMurray
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

4.  Mycobacterium bovis BCG substrains confer different levels of protection against Mycobacterium tuberculosis infection in a BALB/c model of progressive pulmonary tuberculosis.

Authors:  Antonia Isabel Castillo-Rodal; Mauricio Castañón-Arreola; Rogelio Hernández-Pando; Juan José Calva; Eduardo Sada-Díaz; Yolanda López-Vidal
Journal:  Infect Immun       Date:  2006-03       Impact factor: 3.441

5.  Differential expression of gamma interferon mRNA induced by attenuated and virulent Mycobacterium tuberculosis in guinea pig cells after Mycobacterium bovis BCG vaccination.

Authors:  Amminikutty Jeevan; Teizo Yoshimura; Kyeong Eun Lee; David N McMurray
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

Review 6.  The guinea pig as a model of infectious diseases.

Authors:  Danielle J Padilla-Carlin; David N McMurray; Anthony J Hickey
Journal:  Comp Med       Date:  2008-08       Impact factor: 0.982

7.  Characterization of guinea pig T cell responses elicited after EP-assisted delivery of DNA vaccines to the skin.

Authors:  Katherine Schultheis; Hubert Schaefer; Bryan S Yung; Janet Oh; Karuppiah Muthumani; Laurent Humeau; Kate E Broderick; Trevor R F Smith
Journal:  Vaccine       Date:  2016-11-25       Impact factor: 3.641

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.